FDA Adverse Event Injury Summary report: N

OPTETRAK KNEE

MDR report key: 15020156 · Received July 14, 2022

Report

Report Number
1038671-2022-00790
Event Type
Injury
Date Received
July 14, 2022
Date of Event
December 30, 2021
Report Date
February 6, 2023
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862144423
PMA / PMN Number
K111400
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

NO DEVICE RETURN ANTICIPATED. CONCOMITANTS: 02-012-45-1515 - LGC TIBIAL FIT TRAY CEM SZ 1.5F / 1.5T; 02-010-03-0215 - LOGIC CR FEMORAL CEM, LEFT SZ 1.5; 200-02-29 - THREE PEG PATELLA 29MM. ADDITIONAL INFORMATION, INCLUDING THE PRODUCT INVESTIGATION, WILL BE SUBMITTED WITHIN 30 DAYS OF RECEIPT.

Additional Manufacturer Narrative · 0

THIS EVENT WAS ALREADY REPORTED UNDER 1038671-2022-00722. THIS IS A DUPLICATE REPORT.

Description of Event or Problem · 0

IT WAS REPORTED VIA A LEGAL FILING THAT A FEMALE PATIENT UNDERWENT REVISION SURGERY APPROXIMATELY 3 YEARS 8 MONTHS POST HER INITIAL LEFT KNEE TKA. INITIALLY IMPLANTED WITH AN OPTETRAK DEVICE, INCLUDING A SIZE 1.5, 13 MM OPTETRAK LOGIC TIBIAL INSERTS MADE OF POLYETHYLENE. THE PLAINTIFF WAS DIAGNOSED WITH FAILED TOTAL ARTHROPLASTY WITH EARLY POLYETHYLENE FAILURE. BEFORE THE REVISION SURGERY, SHE WAS ALSO DIAGNOSED WITH OSTEOMYELITIS IN HER KNEE DUE TO THE BREAKDOWN OF THE POLYETHYLENE. DURING THE REVISION SURGERY, THE PLAINTIFF'S SURGEON STATED, "WE WERE ABLE TO LEVER THE POLYETHYLENE PLASTIC WITH A SMALL OSTEOTOME AND AFTER THIS WAS RETRIEVED, WE THEN INSPECTED THE PLASTIC, NOTED TO HAVE PITTING AND DELAMINATION OF THE MEDIAL ASPECT OF THE TIBIAL POLYETHYLENE. OTHERWISE, THE POLYETHYLENE LOOKED TO BE IN GOOD CONDITION LATERALLY."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2350333 OPTETRAK KNEE PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED JWH EXACTECH, INC. OPTETRAK KNEE UNK 10885862144423

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention